Understand the source comparison
Peptide Clinic Comparison: Key Differentiators
Medical clinic with peptide subspecialty Board-certified physician with functional medicine or anti-aging certification Yes. CMP, hormone panel, condition-specific markers before any prescription 503B-sourced, third-party CoA provided on request Scheduled labs
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Medical clinic with peptide subspecialty
- Board-certified physician with functional medicine or anti-aging certification
- Yes. CMP, hormone panel, condition-specific markers before any prescription
- 503B-sourced, third-party CoA provided on request
- Scheduled labs at 4, 8, 12 weeks with dose titration based on quantitative outcomes
- Highest standard. Structured medical oversight with individualized dosing adjustments based on objective response data
- Telehealth peptide service (legitimate)
- Licensed NP or PA under physician collaboration, peptide-specific training documented
- Yes. Labs required but patient-sourced or ordered through partner labs
- 503B-sourced, facility name disclosed, CoA available but not always provided proactively
- Scheduled telehealth check-ins at 4–8 week intervals, labs reviewed but not always required for continuation
- Adequate if follow-up is structured. Quality depends on prescriber training and whether dose adjustments occur based on labs or symptoms alone
- Cash-pay 'wellness' clinic
- Physician or NP, anti-aging focus, minimal peptide-specific training verification
- Sometimes. Intake form asks for recent labs but doesn't require new baseline testing
- Facility name not disclosed or sourced from 503A pharmacy without third-party testing documentation
- Optional follow-up or symptom-based check-ins without scheduled lab monitoring
- Inconsistent. Some operate with medical rigor, others prioritize patient volume over protocol individualization, hard to assess without direct sourcing verification
- Online marketplace model
- Prescriber not named until after payment, credentials vary by jurisdiction
- No. Templated protocols with fixed dosing, no lab requirement
- Facility not disclosed, no CoA access, 'pharmaceutical-grade' claimed without documentation
- No structured follow-up. Refills processed automatically unless patient cancels
- Highest risk. No prescriber accountability, no sourcing transparency, no outcome tracking, operates more like supplement sales than medical practice